PFAS,社会的,行動的要因が肝臓の健康に及ぼす影響
Akua Marfo1,2, Emmanuel Obeng-Gyasi1,2
1Department of Built Environment, North Carolina A&T State University, Greensboro, NC 27411, USA.
Medical sciences (Basel, Switzerland)
|August 22, 2025
まとめ
アルコールや喫煙などの社会や行動要因は PFASの曝露よりも肝臓の健康に大きく影響します ライフスタイルと社会経済的な地位は 肝臓の機能の維持に 重要な役割を果たします
科学分野:
- 環境 健康
- ヘパトロジー
- 公衆衛生
背景:
- 肝臓の健康に及ぼす環境曝露 (PFAS) と社会行動要因の組み合わせを調査する.
- 2017~2018年の米国国民健康栄養調査 (NHANES) のデータを活用した.
- 懸念される主なPFASとして,フルオロクタン酸 (PFOA) とフルオロクタン硫酸 (PFOS) に焦点を当てています.
研究 の 目的:
- PFAS,アルコール摂取,喫煙,収入,教育が肝臓機能のバイオマーカーに及ぼす影響を評価する.
- 肝臓の健康への非線形および相互作用的影響を調査する.
- 肝臓のバイオマーカーに対する環境的および社会行動的要因の相対的な影響を決定する.
主な方法:
- LC-MS/MSを用いて分析したPFAS濃度
- バイオマーカー (ALT,AST,ALP,GGT,総ビリルビン,FLI) で肝機能の評価
- 多変量線形回帰とベイジアン・カーネル・マシン回帰 (BKMR) を用いて,関連と相互作用を分析し,後続的インクルージョン確率 (PIP) を計算した.
主要な成果:
- アルコールと喫煙は肝臓のバイオマーカー,特にGGTと総ビリルビン (PIPは1. 0に近い) の最も有力な予測因子でした.
- 収入と教育は,いくつかの肝臓損傷バイオマーカーと逆の関連性を示し,教育はPFASよりもALTとGGTのPIPを高めた.
- PFASは小規模で有意でない回帰係数と低いPIPによって特徴づけられた,肝臓のアウトカムとの関連が弱かった.
結論:
- 変更可能なライフスタイル要因 (アルコール,喫煙) と構造的決定因子 (収入,教育) は,PFASよりも肝臓のバイオマーカーに直接的で顕著な影響を及ぼします.
- 肝臓の健康管理において環境要因と社会行動要因の両方を考慮する重要性を強調する.
- PFASは長期的な懸念ですが,一般の人々の肝臓の健康を改善するために,即時の介入はライフスタイルと社会経済的要因に焦点を当てなければなりません.
関連する概念動画
Types of Toxins
2.0K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
2.0K
Stress Prevention and Stress Management Techniques IV
62
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
62
Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K
Stress and Mental Health
211
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
211
Factors Affecting Drug Biotransformation: Biological
235
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
235
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
371
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
371


